Loading…
image

Report Scope & Overview:

Biopsy Instruments Market size was valued at USD 2.11 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.1% from 2023 to 2030.

Biopsy Instruments Market Overview:
Global Biopsy Instruments Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. Biopsy Instruments Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
Overall, Biopsy Instruments market plays a crucial role in helping businesses and organizations make informed decisions based on data-driven insights. As the demand for data-driven decision-making continues to grow, Biopsy Instruments market research is expected to experience further growth and innovation in the coming years.

DESCIMG1

Biopsy Instruments Market Report Growth Factor

Increasing Prevalence of Cancer: Cancer is a leading cause of mortality worldwide, and the incidence of various types of cancer continues to rise. Biopsy instruments are essential for diagnosing and staging cancer. The increasing prevalence of cancer drives the demand for biopsy instruments.

Technological Advancements: Advancements in biopsy instrument technology have improved the accuracy, efficiency, and safety of biopsy procedures. For example, the development of minimally invasive biopsy techniques, such as core needle biopsies and vacuum-assisted biopsies, have reduced patient discomfort and provided more accurate sampling. Technological innovations attract healthcare providers and contribute to market growth.

Rising Demand for Early Disease Diagnosis: Early diagnosis is crucial for effective treatment and improved patient outcomes. Biopsy instruments play a significant role in the early detection of diseases, including cancer. The growing emphasis on early disease diagnosis, along with increased awareness among patients and healthcare providers, drives the demand for biopsy instruments.

Increasing Aging Population: The global population is aging, and the incidence of age-related diseases, such as cancer, is higher among the elderly. The aging population creates a larger patient pool requiring diagnostic procedures, including biopsies, leading to increased demand for biopsy instruments.

Growing Awareness and Screening Programs: Awareness campaigns, public health initiatives, and screening programs for various cancers have gained momentum. These programs aim to detect cancer at an early stage and encourage individuals to undergo diagnostic procedures, including biopsies. The increasing awareness and implementation of screening programs contribute to the growth of the biopsy instruments market.

Expansion of Healthcare Infrastructure: Developing countries are investing in the improvement of healthcare infrastructure, including the availability of advanced diagnostic facilities. The expansion of healthcare infrastructure in emerging economies creates opportunities for the biopsy instruments market to expand its presence in these regions.

Increasing Adoption of Minimally Invasive Procedures: Minimally invasive procedures offer benefits such as reduced trauma, shorter recovery times, and lower healthcare costs. Biopsy instruments, such as endoscopic forceps and laparoscopic instruments, play a crucial role in minimally invasive procedures. The increasing adoption of these procedures drives the demand for biopsy instruments


Market Segmentations:

Global Biopsy Instruments Market: By Company
• C. R. Bard, Inc.
• Becton, Dickinson and Company
• Cook Group Incorporated
• Devicor Medical Products, Inc. (A Part of Leica Biosystems)
• Argon Medical Devices, Inc.
• B. Braun Melsungen AG
• Cardinal Health, Inc.
• Olympus Corporation
• Boston Scientific Corporation
• Fujifilm Holdings Corporation
• Inrad, Inc.
• Medtronic PLC
• Geotek Medical

Global Biopsy Instruments Market: By Type
• Core Needle Biopsy
• Aspiration Biopsy
• Vacuum Assisted Biopsy

Global Biopsy Instruments Market: By Application
• Hospitals
• Academic and Research Institutes
• Diagnostic and Imaging Centers

Global Biopsy Instruments Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Biopsy Instruments market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.

Report Attribute/MetricDetails
Market Size 2022USD 2.11  billion 
Compound Annual Growth Rate (CAGR) 7.1%(2021-2029)
Base Year2021
Forecast Period2023-2030
Historical Data2018-2020
Forecast UnitsValue (USD Billion)
Report CoverageRevenue Forecast, Competitive Landscape,
Growth Factors, and Trends 
Segments CoveredBy Company, By Type, By Application and By Region
Key Companies ProfiledC. R. Bard, Inc.,  Becton, Dickinson and Company, Cook Group Incorporated,  Devicor Medical Products, Inc. (A Part of Leica Biosystems), Argon Medical Devices, Inc., B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Fujifilm Holdings Corporation,  Inrad, Inc., Medtronic PLC, Geotek Medical
Regions and Key Countries CoveredU.S., Canada, and Mexico in North America, Germany, France, U.K.,
Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium,
and Rest of Europe in Europe, Singapore, Malaysia, Australia,
Thailand, Indonesia, Philippines, China, Japan, India,
South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC),
Saudi Arabia, U.A.E, South Africa, Egypt, Israel,
Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA),
and Argentina, Brazil, and Rest of South America as part of South America


Reasons to Purchase Biopsy Instruments Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Overall, market research reports provide businesses and organizations with valuable information that can help them make informed decisions and stay competitive in their industry. They can provide a solid foundation for business planning, strategy development, and decision-making.

Objectives of Biopsy Instruments Market Study:
The objectives of Biopsy Instruments market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Biopsy Instruments market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Overall, the objectives of Biopsy Instruments market research report are to provide businesses and organizations with valuable insights and data-driven recommendations that can help them make informed business decisions and stay competitive in their industry.

Frequently Asked Questions

  Biopsy Instruments Market size was valued at USD 2.11 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.1% from 2023 to 2030.

  Biopsy instruments are medical devices used to obtain tissue samples from the body for diagnostic or research purposes. They are designed to safely and accurately extract tissue samples from various organs or lesions to aid in the detection and diagnosis of diseases, such as cancer.

  The growth of the biopsy instruments market is driven by factors such as the increasing incidence of cancer and other diseases requiring tissue diagnosis, advancements in biopsy techniques and technologies, a growing geriatric population, rising awareness about the importance of early disease detection, and the need for minimally invasive diagnostic procedures.

  The biopsy instruments market is expected to witness significant growth across regions such as North America, Europe, Asia Pacific, and the rest of the world. Factors such as the high prevalence of cancer, improving healthcare infrastructure, rising healthcare expenditure, and the presence of key market players contribute to market growth in these regions.

  The biopsy instruments market faces challenges such as the high cost of advanced biopsy instruments, limited reimbursement coverage for certain biopsy procedures, the risk of complications associated with invasive biopsies, and the need for skilled professionals for accurate sample collection. Additionally, regulatory compliance and quality control requirements pose challenges to market players.

TABLE OF CONTENT

1 Biopsy Instruments Market Overview
1.1 Product Overview and Scope of Biopsy Instruments
1.2 Biopsy Instruments Segment by Type
1.2.1 Global Biopsy Instruments Market Value Comparison by Type (2023-2029)
1.2.2 Core Needle Biopsy
1.2.3 Aspiration Biopsy
1.2.4 Vacuum Assisted Biopsy
1.3 Biopsy Instruments Segment by Application
1.3.1 Global Biopsy Instruments Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Academic and Research Institutes
1.3.4 Diagnostic and Imaging Centers
1.4 Global Biopsy Instruments Market Size Estimates and Forecasts
1.4.1 Global Biopsy Instruments Revenue 2017-2032
1.4.2 Global Biopsy Instruments Sales 2017-2032
1.4.3 Global Biopsy Instruments Market Average Price (2017-2032)
1.5 Assumptions and Limitations
2 Biopsy Instruments Market Competition by Manufacturers
2.1 Global Biopsy Instruments Sales Market Share by Manufacturers (2017-2023)
2.2 Global Biopsy Instruments Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Biopsy Instruments Average Price by Manufacturers (2017-2023)
2.4 Global Biopsy Instruments Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Biopsy Instruments, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biopsy Instruments, Product Type & Application
2.7 Biopsy Instruments Market Competitive Situation and Trends
2.7.1 Biopsy Instruments Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Biopsy Instruments Players Market Share by Revenue
2.7.3 Global Biopsy Instruments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biopsy Instruments Retrospective Market Scenario by Region
3.1 Global Biopsy Instruments Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Biopsy Instruments Global Biopsy Instruments Sales by Region: 2017-2032
3.2.1 Global Biopsy Instruments Sales by Region: 2017-2023
3.2.2 Global Biopsy Instruments Sales by Region: 2023-2032
3.3 Global Biopsy Instruments Global Biopsy Instruments Revenue by Region: 2017-2032
3.3.1 Global Biopsy Instruments Revenue by Region: 2017-2023
3.3.2 Global Biopsy Instruments Revenue by Region: 2023-2032
3.4 North America Biopsy Instruments Market Facts & Figures by Country
3.4.1 North America Biopsy Instruments Market Size by Country: 2018 VS 2023 VS 2032
3.4.2 North America Biopsy Instruments Sales by Country (2017-2032)
3.4.3 North America Biopsy Instruments Revenue by Country (2017-2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Biopsy Instruments Market Facts & Figures by Country
3.5.1 Europe Biopsy Instruments Market Size by Country: 2018 VS 2023 VS 2032
3.5.2 Europe Biopsy Instruments Sales by Country (2017-2032)
3.5.3 Europe Biopsy Instruments Revenue by Country (2017-2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biopsy Instruments Market Facts & Figures by Country
3.6.1 Asia Pacific Biopsy Instruments Market Size by Country: 2018 VS 2023 VS 2032
3.6.2 Asia Pacific Biopsy Instruments Sales by Country (2017-2032)
3.6.3 Asia Pacific Biopsy Instruments Revenue by Country (2017-2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Biopsy Instruments Market Facts & Figures by Country
3.7.1 Latin America Biopsy Instruments Market Size by Country: 2018 VS 2023 VS 2032
3.7.2 Latin America Biopsy Instruments Sales by Country (2017-2032)
3.7.3 Latin America Biopsy Instruments Revenue by Country (2017-2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biopsy Instruments Market Facts & Figures by Country
3.8.1 Middle East and Africa Biopsy Instruments Market Size by Country: 2018 VS 2023 VS 2032
3.8.2 Middle East and Africa Biopsy Instruments Sales by Country (2017-2032)
3.8.3 Middle East and Africa Biopsy Instruments Revenue by Country (2017-2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Biopsy Instruments Sales by Type (2017-2032)
4.1.1 Global Biopsy Instruments Sales by Type (2017-2023)
4.1.2 Global Biopsy Instruments Sales by Type (2023-2032)
4.1.3 Global Biopsy Instruments Sales Market Share by Type (2017-2032)
4.2 Global Biopsy Instruments Revenue by Type (2017-2032)
4.2.1 Global Biopsy Instruments Revenue by Type (2017-2023)
4.2.2 Global Biopsy Instruments Revenue by Type (2023-2032)
4.2.3 Global Biopsy Instruments Revenue Market Share by Type (2017-2032)
4.3 Global Biopsy Instruments Price by Type (2017-2032)
5 Segment by Application
5.1 Global Biopsy Instruments Sales by Application (2017-2032)
5.1.1 Global Biopsy Instruments Sales by Application (2017-2023)
5.1.2 Global Biopsy Instruments Sales by Application (2023-2032)
5.1.3 Global Biopsy Instruments Sales Market Share by Application (2017-2032)
5.2 Global Biopsy Instruments Revenue by Application (2017-2032)
5.2.1 Global Biopsy Instruments Revenue by Application (2017-2023)
5.2.2 Global Biopsy Instruments Revenue by Application (2023-2032)
5.2.3 Global Biopsy Instruments Revenue Market Share by Application (2017-2032)
5.3 Global Biopsy Instruments Price by Application (2017-2032)
6 Key Companies Profiled
6.1 C. R. Bard, Inc.
6.1.1 C. R. Bard, Inc. Corporation Information
6.1.2 C. R. Bard, Inc. Description and Business Overview
6.1.3 C. R. Bard, Inc. Biopsy Instruments Sales, Revenue and Gross Margin (2017-2023)
6.1.4 C. R. Bard, Inc. Biopsy Instruments Product Portfolio
6.1.5 C. R. Bard, Inc. Recent Developments/Updates
6.2 Becton, Dickinson and Company
6.2.1 Becton, Dickinson and Company Corporation Information
6.2.2 Becton, Dickinson and Company Description and Business Overview
6.2.3 Becton, Dickinson and Company Biopsy Instruments Sales, Revenue and Gross Margin (2017-2023)
6.2.4 Becton, Dickinson and Company Biopsy Instruments Product Portfolio
6.2.5 Becton, Dickinson and Company Recent Developments/Updates
6.3 Cook Group Incorporated
6.3.1 Cook Group Incorporated Corporation Information
6.3.2 Cook Group Incorporated Description and Business Overview
6.3.3 Cook Group Incorporated Biopsy Instruments Sales, Revenue and Gross Margin (2017-2023)
6.3.4 Cook Group Incorporated Biopsy Instruments Product Portfolio
6.3.5 Cook Group Incorporated Recent Developments/Updates
6.4 Devicor Medical Products, Inc. (A Part of Leica Biosystems)
6.4.1 Devicor Medical Products, Inc. (A Part of Leica Biosystems) Corporation Information
6.4.2 Devicor Medical Products, Inc. (A Part of Leica Biosystems) Description and Business Overview
6.4.3 Devicor Medical Products, Inc. (A Part of Leica Biosystems) Biopsy Instruments Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Devicor Medical Products, Inc. (A Part of Leica Biosystems) Biopsy Instruments Product Portfolio
6.4.5 Devicor Medical Products, Inc. (A Part of Leica Biosystems) Recent Developments/Updates
6.5 Argon Medical Devices, Inc.
6.5.1 Argon Medical Devices, Inc. Corporation Information
6.5.2 Argon Medical Devices, Inc. Description and Business Overview
6.5.3 Argon Medical Devices, Inc. Biopsy Instruments Sales, Revenue and Gross Margin (2017-2023)
6.5.4 Argon Medical Devices, Inc. Biopsy Instruments Product Portfolio
6.5.5 Argon Medical Devices, Inc. Recent Developments/Updates
6.6 B. Braun Melsungen AG
6.6.1 B. Braun Melsungen AG Corporation Information
6.6.2 B. Braun Melsungen AG Description and Business Overview
6.6.3 B. Braun Melsungen AG Biopsy Instruments Sales, Revenue and Gross Margin (2017-2023)
6.6.4 B. Braun Melsungen AG Biopsy Instruments Product Portfolio
6.6.5 B. Braun Melsungen AG Recent Developments/Updates
6.7 Cardinal Health, Inc.
6.6.1 Cardinal Health, Inc. Corporation Information
6.6.2 Cardinal Health, Inc. Description and Business Overview
6.6.3 Cardinal Health, Inc. Biopsy Instruments Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Cardinal Health, Inc. Biopsy Instruments Product Portfolio
6.7.5 Cardinal Health, Inc. Recent Developments/Updates
6.8 Olympus Corporation
6.8.1 Olympus Corporation Corporation Information
6.8.2 Olympus Corporation Description and Business Overview
6.8.3 Olympus Corporation Biopsy Instruments Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Olympus Corporation Biopsy Instruments Product Portfolio
6.8.5 Olympus Corporation Recent Developments/Updates
6.9 Boston Scientific Corporation
6.9.1 Boston Scientific Corporation Corporation Information
6.9.2 Boston Scientific Corporation Description and Business Overview
6.9.3 Boston Scientific Corporation Biopsy Instruments Sales, Revenue and Gross Margin (2017-2023)
6.9.4 Boston Scientific Corporation Biopsy Instruments Product Portfolio
6.9.5 Boston Scientific Corporation Recent Developments/Updates
6.10 Fujifilm Holdings Corporation
6.10.1 Fujifilm Holdings Corporation Corporation Information
6.10.2 Fujifilm Holdings Corporation Description and Business Overview
6.10.3 Fujifilm Holdings Corporation Biopsy Instruments Sales, Revenue and Gross Margin (2017-2023)
6.10.4 Fujifilm Holdings Corporation Biopsy Instruments Product Portfolio
6.10.5 Fujifilm Holdings Corporation Recent Developments/Updates
6.11 Inrad, Inc.
6.11.1 Inrad, Inc. Corporation Information
6.11.2 Inrad, Inc. Biopsy Instruments Description and Business Overview
6.11.3 Inrad, Inc. Biopsy Instruments Sales, Revenue and Gross Margin (2017-2023)
6.11.4 Inrad, Inc. Biopsy Instruments Product Portfolio
6.11.5 Inrad, Inc. Recent Developments/Updates
6.12 Medtronic PLC
6.12.1 Medtronic PLC Corporation Information
6.12.2 Medtronic PLC Biopsy Instruments Description and Business Overview
6.12.3 Medtronic PLC Biopsy Instruments Sales, Revenue and Gross Margin (2017-2023)
6.12.4 Medtronic PLC Biopsy Instruments Product Portfolio
6.12.5 Medtronic PLC Recent Developments/Updates
6.13 Geotek Medical
6.13.1 Geotek Medical Corporation Information
6.13.2 Geotek Medical Biopsy Instruments Description and Business Overview
6.13.3 Geotek Medical Biopsy Instruments Sales, Revenue and Gross Margin (2017-2023)
6.13.4 Geotek Medical Biopsy Instruments Product Portfolio
6.13.5 Geotek Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biopsy Instruments Industry Chain Analysis
7.2 Biopsy Instruments Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biopsy Instruments Production Mode & Process
7.4 Biopsy Instruments Sales and Marketing
7.4.1 Biopsy Instruments Sales Channels
7.4.2 Biopsy Instruments Distributors
7.5 Biopsy Instruments Customers
8 Biopsy Instruments Market Dynamics
8.1 Biopsy Instruments Industry Trends
8.2 Biopsy Instruments Market Drivers
8.3 Biopsy Instruments Market Challenges
8.4 Biopsy Instruments Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

C. R. Bard, Inc.
Becton, Dickinson and Company
Cook Group Incorporated
Devicor Medical Products, Inc. (A Part of Leica Biosystems)
Argon Medical Devices, Inc.
B. Braun Melsungen AG
Cardinal Health, Inc.
Olympus Corporation
Boston Scientific Corporation
Fujifilm Holdings Corporation
Inrad, Inc.
Medtronic PLC
Geotek Medical

Request Sample